Neumora Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for Neumora Therapeutics stock have an average target of 8.00, with a low estimate of 1.00 and a high estimate of 18. The average target predicts an increase of 260.36% from the current stock price of 2.22.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$1.00	$8.00	$7.00	$18
Change	-54.95%	+260.36%	+215.32%	+710.81%

Analyst Ratings

The average analyst rating for Neumora Therapeutics stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	2	2	2	3	3	3
Buy	1	1	1	1	1	2
Hold	4	4	3	2	2	1
Sell	1	1	2	2	2	2
Strong Sell	0	0	0	0	0	0
Total	8	8	8	8	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Brian Abrahams RBC Capital	RBC Capital	Hold → Buy Upgrades $4 → $7	Hold → Buy	Upgrades	$4 → $7	+215.32%	Dec 1, 2025
Paul Matteis Stifel	Stifel	Hold Maintains $2 → $3	Hold	Maintains	$2 → $3	+35.14%	Nov 17, 2025
Ami Fadia Needham	Needham	Strong Buy Maintains $6 → $8	Strong Buy	Maintains	$6 → $8	+260.36%	Oct 28, 2025
Yatin Suneja Guggenheim	Guggenheim	Hold → Strong Buy Upgrades $14	Hold → Strong Buy	Upgrades	$14	+530.63%	Oct 27, 2025
Tessa Romero JP Morgan	JP Morgan	Hold → Sell Downgrades n/a	Hold → Sell	Downgrades	n/a	n/a	Sep 16, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

4.25M

EPS This Year

-1.46

from -1.53

EPS Next Year

-1.08

from -1.46

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-	4.25M
Revenue Growth	-	-	-	-	-	-	-
EPS	-7.64	-10.84	-4.81	-3.63	-1.53	-1.46	-1.08
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	10	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	n/a	26.3M
Avg	n/a	4.3M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-1.46	-0.67
Avg	-1.46	-1.08
Low	-1.44	-1.42

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.